TrialInternational journal of hematology2009

A study of rasburicase for the management of hyperuricemia in pediatric patients with newly diagnosed hematologic malignancies at high risk for tumor lysis syndrome.

Akira Kikuchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.